Literature DB >> 9514536

Membrane-type matrix metalloproteinase-1(MT1-MTP) gene is overexpressed in highly invasive hepatocellular carcinomas.

T Harada1, S Arii, M Mise, T Imamura, H Higashitsuji, M Furutani, M Niwano, S Ishigami, M Fukumoto, M Seiki, H Sato, M Imamura.   

Abstract

BACKGROUND/AIMS: The matrix metalloproteinase (MMP) family play important roles in the invasion of cancer cells by degrading the extracellular matrices. The current study was designed to determine the expression pattern of membrane-type matrix metalloproteinase-1 (MT1-MMP) in hepatocellular carcinomas and its participation in invasion potential.
METHODS: MT1-MMP mRNA expression was examined in 25 human hepatocellular carcinoma specimens using Northern blot, and the correlation to clinicopathological features was evaluated. In situ hybridization and immunohistochemistry were performed to study the localization and the cells responsible for the production.
RESULTS: Northern blot analysis revealed high levels of MT1-MMP mRNA expression in tumorous portions in all cases, whereas in non-tumorous portions moderate or faint expression was evident in 22/25 cases. In 21/25 cases, the expression levels in tumorous portion were higher than those in non-tumorous portion. In particular, hepatocellular carcinoma with capsule infiltration demonstrated significantly higher expression than those without (p<0.05). In situ hybridization and immunohistochemical study revealed MT1-MMP transcripts and proteins in cancer cells and stromal cells, respectively. MT1-MMP positive cells were preferentially observed in the invading border of tumor nests. The MMP-2 transcript showed a similar pattern to that of MT1-MMP by in situ hybridization.
CONCLUSION: The present study showed that the MT1-MMP gene is strongly expressed in hepatocellular carcinoma cells and is involved in the invasion potential of hepatocellular carcinoma, and also that MT1-MMP may be one of the key molecules responsible for the invasion potential of hepatocellular carcinoma. Furthermore, the evidence suggests that MT1-MMP and MMP-2 cooperate in the process of cancer invasion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9514536     DOI: 10.1016/0168-8278(88)80010-2

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  19 in total

1.  Invasiveness of hepatocellular carcinoma cell lines: contribution of membrane-type 1 matrix metalloproteinase.

Authors:  K Murakami; R Sakukawa; T Ikeda; T Matsuura; S Hasumura; S Nagamori; Y Yamada; I Saiki
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

2.  Mechanism of metastasis by membrane type 1-matrix metalloproteinase in hepatocellular carcinoma.

Authors:  Ying-Chi Ip; Siu-Tim Cheung; Ka-Ling Leung; Sheung-Tat Fan
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

3.  The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression.

Authors:  Enrique Lara-Pezzi; Maria Victoria Gómez-Gaviro; Beatriz G Gálvez; Emilia Mira; Miguel A Iñiguez; Manuel Fresno; Carlos Martínez-A; Alicia G Arroyo; Manuel López-Cabrera
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

4.  Down-regulation of methylthioadenosine phosphorylase (MTAP) induces progression of hepatocellular carcinoma via accumulation of 5'-deoxy-5'-methylthioadenosine (MTA).

Authors:  Georgi Kirovski; Axel P Stevens; Barbara Czech; Katja Dettmer; Thomas S Weiss; Peter Wild; Arndt Hartmann; Anja K Bosserhoff; Peter J Oefner; Claus Hellerbrand
Journal:  Am J Pathol       Date:  2011-01-28       Impact factor: 4.307

Review 5.  The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis.

Authors:  A John; G Tuszynski
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

6.  Evaluation of Apoptotic Marker Bcl2, CD4+, Human Hepatocyte Growth Factor and Metalloproteinase-9 as Tumor Markers for Patients with Hepatocellular Carcinoma.

Authors:  Eman R Youness; Mohamed El Nemr; F S Oraby; Nadia M Ahmed; Mohamed A Moghni; Hanan F Aly; Hanaa H Ahmed
Journal:  Indian J Clin Biochem       Date:  2013-09-08

Review 7.  Molecular targeted therapy for advanced hepatocellular carcinoma: current status and future perspectives.

Authors:  Ying-Chun Shen; Chiun Hsu; Ann-Lii Cheng
Journal:  J Gastroenterol       Date:  2010-06-22       Impact factor: 6.772

8.  C2-O-sLeX glycoproteins are E-selectin ligands that regulate invasion of human colon and hepatic carcinoma cells.

Authors:  Catherine A St Hill; Dahabo Baharo-Hassan; Mariya Farooqui
Journal:  PLoS One       Date:  2011-01-19       Impact factor: 3.240

9.  Snail accelerates cancer invasion by upregulating MMP expression and is associated with poor prognosis of hepatocellular carcinoma.

Authors:  A Miyoshi; Y Kitajima; S Kido; T Shimonishi; S Matsuyama; K Kitahara; K Miyazaki
Journal:  Br J Cancer       Date:  2005-01-31       Impact factor: 7.640

10.  Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers.

Authors:  E Kerkelä; R Ala-aho; J Lohi; R Grénman; V M-Kähäri; U Saarialho-Kere
Journal:  Br J Cancer       Date:  2001-03-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.